The persistence of antibodies in ESRD patients 12 months after the BNT162B2 vaccine booster dose.

• Main Authors: Zainulabid, Ummu Afeera, Hashim, Mohammad Hanif, Abd Mokti, Abdullah Shamshir, Mohd Azraai, Awla, Ahmad, Hajar Fauzan, Gazali, Ahmad Mahfuz
• Format: Article
• Language: English
• Published: UniKL Royal College of Medicine Perak (UniKL RCMP) 2024
• Subjects: RC111 Infectious and Parasitic Diseases
• Online Access: http://irep.iium.edu.my/113313/7/113313_The%20persistence%20of%20antibodies%20in%20ESRD%20patients%2012%20months.pdf; http://irep.iium.edu.my/113313/; https://www.ajmhsrcmp.org/#page/1

End-stage renal disease (ESRD) patients undergoing haemodialysis have been reported to have impaired humoral response after coronavirus disease 2019 vaccination. However, most studies focus on one antibody profile or one-time point only. Here, we longitudinally investigate the antibody response towa...